Bayspair offers licensing of its proprietary genome editing technology for research purposes as well as for use in all areas, including industrial, therapeutic and diagnostic, and agricultural commercial purposes. In addition, Bayspair also promotes partnerships for collaborative research and development of genome editing products and welcomes all proposals, including those from academia, start-ups, and large companies. Please contact us for more information.